Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q4 earnings results on Wednesday, March 2, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Intercept Pharmaceuticals missed estimated earnings by 11.82%, reporting an EPS of $-1.23 versus an estimate of $-1.1.
Revenue was up $9.14 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.46 which was followed by a 1.29% drop in the share price the next day.
Here's a look at Intercept Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1.09 | -1.21 | -1.44 | -1.47 |
| EPS Actual | -0.63 | -0.33 | -1.22 | -1.58 |
| Revenue Estimate | 83.02M | 82.95M | 81.20M | 85.01M |
| Revenue Actual | 92.83M | 96.58M | 81.66M | 83.27M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
